USD 7.99 Billion
Osteoarthritis Therapeutics Market Size, Share, Growth Analysis, By Anatomy (Knee Osteoarthritis, Hip Osteoarthritis), By Drug Type (Viscosupplementation Agents, Non-Steroidal Anti-inflammatory Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies), By Region -Industry Forecast 2025-2032
Report ID:
SQMIG30K2057 |
Region:
Global |
Published Date: December, 2024
Pages:
166
|Tables:
92
|Figures:
71
Osteoarthritis Therapeutics Market Insights
Global Osteoarthritis Therapeutics Market size was valued at USD 7.99 Billion in 2022 poised to grow from USD 8.54 Billion in 2023 to USD 14.56 Billion by 2031, growing at a CAGR of 6.89% in the forecast period (2024-2031).
Considering that osteoarthritis is increasingly among the common diseases especially in old people and lot of R&D is going in developing newer therapeutics for osteoarthritis; hence, the market is predicted to grow to huge new heights. More than 32.5 million Americans suffer from osteoarthritis according to CDC data on January 2023, which shows the growing need for efficacious therapies. Market expansion is anticipated to be further fuelled by ongoing developments in the understanding of diseases and the creation of treatment solutions. The main causes of women's increased risk include musculoskeletal abnormalities and hormonal changes related to menstruation and menopause.
Moreover, according to the National Institutes of Health, in the United States females are more likely to have obesity than males, which, in turn, predisposes them to osteoarthritis. Thus, the presence of such statistics highlights that osteoarthritis is one prevalent and costly condition disparately burdens women, causing the projections of market growth and the development of targeted solutions for the whole projected period. OA's thick and avascular tissue nature makes management extremely difficult. However, specific medication delivery systems have been developed because of the introduction of intra-articular (IA) drug administration. Research and development for new OA treatments is expected to be improved by the focus on disease-modifying medications and bioadaptive carriers.
Market snapshot - 2024-2031
Global Market Size
Largest Segment
Knee Osteoarthritis
Fastest Growth
Hip Osteoarthritis
Growth Rate
6.89% CAGR
Global Osteoarthritis Therapeutics Market ($ Bn)
Country Share by North America (%)
To get more reports on the above market click here to Buy The Report
Osteoarthritis Therapeutics Market Segmental Analysis
The global osteoarthritis therapeutics market is segmented based on anatomy, drug type, distribution channel, and region. In terms of anatomy, the market is grouped into knee osteoarthritis, hip osteoarthritis, hand osteoarthritis, and small joint osteoarthritis. Based on drug type, the market is segmented into viscosupplementation agents, non-steroidal anti-inflammatory drugs, analgesics, and corticosteroids. Based on distribution channel, the market is trifurcated into hospital pharmacies, retail pharmacies, and online pharmacies. Based on region, the market is segmented into North America, Europe, Asia-Pacific, Central & South America and the Middle East & Africa.
Analysis by Anatomy
As per categorization by anatomy, the market is classified as built in knee osteoarthritis, hip osteoarthritis, hand osteoarthritis, and small joint osteoarthritis. Among these, knee osteoarthritis earned the largest share and continues to hold the dominant global osteoarthritis therapeutics market share. Knee osteoarthritis still remains one of the greatest areas of attention within the global osteoarthritis therapeutics market, primarily due to its prevalence and its major effects on mobility- especially among the elderly. Advances in the innovation of treatments-such as the newer biologics, regenerative therapies such as stem cell injections, and personalized medicine-continue to be gaining traction. Knee OA spearheads market dominance due to its wide occurrence in adults and debilitating effects that create a need for attending to demand through physical therapy, surgical options, and pharma approaches.
Hip osteoarthritis is expected to be the fastest-growing segment in the global osteoarthritis therapeutics market due to an aging global population and increasing risk factors such as obesity and sedentary lifestyles. It has been increased demand for advanced treatments such as biologics, regenerative medicine, or less invasive surgeries as elder hip osteoarthritis leads to high disability and lower quality of life. Additionally, increasing awareness and advancement in diagnostic technologies drive early detection as well, which is a further impetus for adopting treatment. As healthcare providers focus on personalized, effective intervention, the hip OA therapeutics market is going to ramp up speed, meeting the urgent need for better care options.
Analysis by Drug Type
Non-Steroidal Anti-inflammatory Drugs (NSAIDs) continue to dominate the global osteoarthritis therapeutics market due to their effectiveness in managing pain and inflammation. New formulations of NSAIDs, including topical preparations and extended-release forms, promise enhanced patient adherence and lower gastrointestinal adverse effects. The first line of treatment remains NSAIDs, as they have been outdone by biologic and regenerative approaches, but also due to being inexpensive, widely available, and effective in relieving pain. The large number of patients who receive NSAIDs for all stages of osteoarthritis, and the continual betterment of safety profiles, keep NSAIDs ahead of the market while also ensuring optimal relief to patients regarding symptom control.
Visco supplementation agents are expected to be the fastest-growing segment in the global osteoarthritis therapeutics market due to their ability to provide long-lasting pain relief and improve joint function, particularly in knee osteoarthritis. These injectables are made mostly using hyaluronic acid, which is being administered to restore the lubricating property of synovial fluid in order to lessen friction and inflammation in that diseased joint. This treatment has increased patient flow in favor of this method of therapy, where individuals may choose to have Visco supplementation over oral medication or replacement surgery compared to increasing demand for other types of minimally invasive, non-surgery techniques. There are promising advancements in existing formulations as well as growing clinical evidence that supports effectiveness increases the market share of Visco supplementation agents.
Global Osteoarthritis Therapeutics Market By Anatomy (%)
To get detailed analysis on other segments, Request For Free Sample Report
Osteoarthritis Therapeutics Market Regional Insights
North America dominates the global osteoarthritis therapeutics market due to a combination of factors including a large aging population, high prevalence of osteoarthritis, and advanced healthcare infrastructure. Indeed, the region is said to receive massive healthcare spending, making most available treatment options such as biologics, NSAIDs, and viscosupplementation agents accessible. North America has also been the leading researcher and developer in the space of innovations in therapeutic solutions. Other factors such as government support for improvement in healthcare, along with increasing public awareness of osteoarthritis management, are essential in making the region inherently superior. This, combined with very developed healthcare systems, has given North America dominance over the global osteoarthritis therapeutics market.
Europe is the fastest-growing region in the global osteoarthritis therapeutics market, driven by an aging population and increasing healthcare investments across the continent. The rising incidences of osteoarthritis, particularly in the elder population, are thereby increasing the demand for advanced treatment options like biologics, viscosupplementation, regenerative therapies, etc. It can also be stated that in Europe, new and innovative healthcare solutions are emerging through collaborative research and favorable regulatory environments. The increased adoption of personalized therapies and minimally invasive treatment is some of the other major contributing factors to the overall rapid expansion of the osteoarthritis therapeutics market in Europe, which is driven by the strong focus on improving quality of life for patients.
Global Osteoarthritis Therapeutics Market By Geography
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Osteoarthritis Therapeutics Market Dynamics
Drivers
Aging Population in Developed Nation
- The global osteoarthritis therapeutic market promises great potential in the rapidly aging population, especially in developed parts of the world such as North America and Europe. Since older people tend to suffer joint degenerative diseases, an increased number of older individuals translates directly into higher demand for treatments, ultimately driving market expansion and therapeutic innovation.
Rising Obesity Rates
- Since obesity is increasing worldwide, it is a primary factor driving the global osteoarthritis therapeutics market growth. More weight means more pressure on the joints, especially knee and hip; thereby it hastens the osteoarthritis condition. Thus, this additively encourages the demand for therapies, since they desire instant pain relief and improvement of joint motion.
Restraints
Side Effects of Current Therapies
- The potential side effects associated with conventional osteoarthritis treatments, such as NSAIDs and corticosteroids, are a key restraint. Long-term use of these drugs may lead to developmental gastrointestinal issues, cardiovascular diseases, and more. As a result, the nature of these drugs is deterrent, causing patients to seek alternatives, blocking the mainstream application of these therapies.
Lack of Awareness and Diagnosis
- A lack of awareness about osteoarthritis symptoms and the importance of early diagnosis in certain regions impedes the adoption of treatments. Many prefer to delay going for treatment even when things get bad; early intervention is necessary at times, so the whole process can slow down from that moment into market reach.
Request Free Customization of this report to help us to meet your business objectives.
Osteoarthritis Therapeutics Market Competitive Landscape
The global osteoarthritis therapeutics market is highly competitive, with numerous pharmaceutical companies and biopharmaceutical firms driving innovation. The important players in this sector include Johnson and Johnson, Pfizer, Sanofi, AbbVie, and Merck with their offering of different treatment options like the NSAIDs, biologics, and viscosupplementation agents. The companies are now focusing on research and development, also diversifying products and improving treatment efficiencies to brace themselves for future competition in the market. Partnerships and acquisitions also aid in bolstering the market presence for developing next-generation therapies for osteoarthritis management.
Top Player’s Company Profiles
- Johnson & Johnson (USA)
- Pfizer (USA)
- Sanofi (France)
- AbbVie (USA)
- Merck & Co. (USA)
- GlaxoSmithKline (United Kingdom)
- Novartis (Switzerland)
- Amgen (USA)
- Bristol-Myers Squibb (USA)
- Eli Lilly and Co. (USA)
- Horizon Therapeutics (Ireland)
- Stryker Corporation (USA)
- Zimmer Biomet (USA)
- Mylan Pharmaceuticals (USA)
- Regeneron Pharmaceuticals (USA)
Recent Developments
- In November 2024, AbbVie made known the launching of a new injectable biologic medicine to treat knee osteoarthritis so that patients could gain pain relief and improved joint function for longer periods of time. The therapy will be given to the public due to the efficacy shown in recent clinical trials that will replace the traditional surgical methods into less invasive interventions that will benefit patients.
- In October 2024, Johnson & Johnson unveiled a new advanced viscosupplementation agent aimed at treating knee osteoarthritis. This product is designed to offer superior lubrication and reduce inflammation, offering patients an alternative to oral medications. The company’s strategic R&D investment aims to expand its portfolio of non-surgical osteoarthritis therapies.
- In September 2024, the next generation of NSAID remedy in osteoarthritis development by Merck & Co. has substantially advanced. It aims at pain reduction with a significant decrease in the gastrointestinal side effects, which is one of the limitations of all present-day therapies. Merck shall further strengthen its position in the OA therapeutics market with this product.
Osteoarthritis Therapeutics Key Market Trends
- Rising Adoption of Minimally Invasive Treatments: The shift towards minimal invasive therapies like viscosupplementation and biologic injections, are some of the latest global osteoarthritis therapeutics market trends. These very effective pain relievers as well as joint functional improvements are accompanied with less recovery time than surgeries. Thus, they are becoming more and more popular in the eyes of patients and healthcare providers.
- Growing Demand for Personalized Osteoarthritis Therapies: There is a rising demand for personalized osteoarthritis treatments, tailored to individual patients' genetic profiles and disease stages. Indeed, such advancements in regenerative medicine, biologics, and precision medicine are compelling all these healthcare organizations to really optimize treatment as well as the possible effective long-term outcomes concerning osteoarthritis patients.
Osteoarthritis Therapeutics Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, in conclusion, the global osteoarthritis therapeutics industry is expected to witness a huge surge that would be fueled as prevalently increasing cases of the condition among populations tend to grow within age brackets. Innovative developments aimed at treatment, such as biologics, viscosupplementation agents, and disease-modifying medications, are ensuring that there is a distance between patient profiles.
And as the market demand continues to increase, more companies are trying to develop targeted, personalized therapies for osteoarthritis as it will eventually change in the future and be better and more useful to improve the quality of life for millions of people suffering from it.
| Report Metric | Details |
|---|---|
| Market size value in 2022 | USD 7.99 Billion |
| Market size value in 2031 | USD 14.56 Billion |
| Growth Rate | 6.89% |
| Base year | 2023 |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Osteoarthritis Therapeutics Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Osteoarthritis Therapeutics Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Osteoarthritis Therapeutics Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Osteoarthritis Therapeutics Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Osteoarthritis Therapeutics Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Osteoarthritis Therapeutics Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
